ABB  Vol.5 No.10 , September 2014
Production, Detection and Cross-Reactivity of Anti-Polysaccharide Antibodies from Environmental Fungi
Abstract: The diagnosis of Invasive Fungal Disease (IFD) is difficult because the sensitivity of conventional culture and cytology methods for the detection of Aspergillus is poor, and because serological methods exhibit cross-reactivity with environmental fungi. Fungal polysaccharides are of particular interest in the serologic diagnosis of IFD, especially galactomannan (GM) and glucan, which have been recognized as useful tools for the diagnosis of fungal infections. Further investigation into polysaccharide antibody cross-reactivity is important in improving diagnostic tests. Our aim was to verify the production of antibodies against fungal antigens in mice immunized with exopolysaccharides (EPS) obtained from three fungal species (Aspergillus terreus, Paecilomyces variotii and Curvularia brachyspora). ELISA assays were performed to evaluate homologous and heterologous reactions and showed anti-polysaccharide antibodies production. EPS from A. terreus was immunogenic enough to immunize the animal and lead to antibody production against this EPS. In addition, no cross-reactivity was observed with EPS obtained from P. variotii and C. brachyspora. The EPS from P. variotii did not exhibit good immunogenicity, whereas EPS from C. brachyspora showed good immunogenicity, and heterologous reactions were detected on the ELISA assays performed using the EPS from this species. The results indicate that immunization can occur for environmental fungal polysaccharides, generating antibodies may be interfere in serological diagnosis that are based on detection of fungal polysaccharides, mainly glucans and galactomannans.
Cite this paper: Menolli, R. , Ayala, T. , Rosa, P. , Macedo Costa, C. , Osaku, E. and Mello Zibetti, R. (2014) Production, Detection and Cross-Reactivity of Anti-Polysaccharide Antibodies from Environmental Fungi. Advances in Bioscience and Biotechnology, 5, 815-822. doi: 10.4236/abb.2014.510095.

[1]   Florent, M., Katsahian, S., Vekhoff, A., Levy, V., Rio, B., Marie, J, et al. (2006) Prospective Evaluation of a Polymerase Chain Reaction—ELISA Targeted to Aspergillus fumigatus and Aspergillus flavus for the Early Diagnosis of Invasive Aspergillosis in Patients with Hematological Malignancies. The Journal of Infectious Disease, 193, 741-747.

[2]   Marchetti, O., Lamoth, F., Mikulska, M., Viscoli, C., Verweij, P. and Bretagne, S. (2012) ECIL Recommendations for the Use of Biological Markers for the Diagnosis of Invasive Fungal Diseases in Leukemic Patients and Hematopoietic SCT Recipients. Bone Marrow Transplantation, 47, 846-854.

[3]   Fukuda, T., Boeckh, M., Carter, R.A., Sandmaier, B.M., Maris, M.B., Maloney, D.G., et al. (2003) Risks and Outcomes of Invasive Fungal Infections in Recipients of Allogeneic Hematopoietic Stem Cell Transplants after Nonmyeloablative Conditioning. Blood, 102, 827-833.

[4]   Martino, R. and Subirà, M. (2002) Invasive Fungal Infections in Hematology: New Trends. Annals of Hematology, 81, 233-243.

[5]   Singh, N. and Husain, S. (2003) Aspergillus Infections after Lung Transplantation: Clinical Differences in Type of Transplant and Implications for Management. The Journal of Heart and Lung Transplantation, 22, 258-266.

[6]   Pound, M.W., Drew, R.H. and Perfect, J.R. (2002) Recent Advances in the Epidemiology, Prevention, Diagnosis, and Treatment of Fungal Pneumonia. Current Opinion in Infectious Diseases, 15, 183-194.

[7]   Ascioglu, S., Rex, J.H., De Pauw, B., Bennett, J.E., Bille, J., Crokaert, F., et al. (2002) Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus. Clinical Infectious Diseases, 34, 7-14.

[8]   De Pauw, B., Walsha, T.J., Donnellya, J.P., Stevens, D.A., Edwards, J.E., Calandra, T., et al. (2008) Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive. Clinical Infectious Diseases, 46, 1813-1821.

[9]   Cutler, J.E., Deepe, G.S. and Klein, B.S. (2007) Advances in Combating Fungal Diseases: Vaccines on the Threshold. Nature Reviews Microbiology, 5, 13-28.

[10]   Quindo, G. (2006) New Microbiological Techniques for the Diagnosis of Invasive Mycoses Caused by Filamentous Fungi. Clinical Microbiology and Infection, 12, 40-52.

[11]   Crowell, E.P. and Burnett, B.B. (1967) Determination of the Carbohydrate Composition of Wood Pulps by Gas Chromatography of the Alditol Acetates. Analytical Chemistry, 39, 121-124.

[12]   Cavanna, C., Seminari, E., Pusateri, A., Mangione, F., Lallitto, F., Esposto, M.C., et al. (2014) Allergic Fungal Rhinosinusitis Due to Curvularia lunata. New Microbiologica, 37, 241-245.

[13]   Latgé, J.P. (2010) Tasting the Fungal Cell Wall. Cellular Microbiology, 12, 863-872.

[14]   Kawazu, M., Kanda, Y., Nannya, Y., Aoki, K., Kurokawa, M., Chiba, S., et al. (2004) Prospective Comparison of the Diagnostic Potential of Real-Time PCR, Double-Sandwich Enzyme-Linked Immunosorbent Assay for Galactomannan, and a (1 3)-β-D-Glucan Test in Weekly Screening for Invasive Aspergillosis in Patients with Hematological Disorders. Journal of Clinical Microbiology, 42, 2733-2741.

[15]   Zahradnik, E., Kespohl, S., Sander, I., Schies, U., Khosravie-Hohn, J., Lorenz, W., et al. (2013) A New Immunoassay to Quantify Fungal Antigens from the Indoor Mould Aspergillus versicolor. Environmental Science: Processes & Impacts, 15, 1162-1171.

[16]   Yeo, S.F. and Wong, B. (2002) Current Status of Nonculture Methods for Diagnosis of Invasive Fungal Infections. Clinical Microbiology Reviews, 15, 465-484.

[17]   Pfeiffer, C.D., Fine, J.P. and Safdar, N. (2006) Diagnosis of Invasive Aspergillosis Using a Galactomannan Assay: A Meta-Analysis. Clinical Infectious Diseases, 42, 1417-1427.

[18]   Wheat, L.J. and Walsh, T.J. (2008) Diagnosis of Invasive Aspergillosis by Galactomannan Antigenemia Detection Using an Enzyme Immunoassay. European Journal of Clinical Microbiology & Infectious Diseases, 27, 245-251.

[19]   Douwes, J., Van Der Sluis, B., Doekes, G., Van, F., Wijnands, L., Van Strien, R., et al. (1999) Fungal Extracellular Polysaccharides in House Dust as a Marker for Exposure to Fungi: Relations with Culturable Fungi, Reported Home Dampness, and Respiratory Symptoms. Environmental and Occupational Disorders, 103, 494-500.

[20]   Barton, R.C., Hobson, R.P., Denton, M., Peckham, D., Brownlee, K., Conway, S., et al. (2008) Serologic Diagnosis of Allergic Bronchopulmonary Aspergillosis in Patients with Cystic Fibrosis through the Detection of Immunoglobulin G to Aspergillus fumigatus. Diagnostic Microbiology and Infectious Disease, 62, 287-291.

[21]   Taira, C.L., Marcondes, N.R. and Mota, V.A. (2011) Virulence Potential of Filamentous Fungi Isolated from Poultry Barns in Cascavel, Paraná, Brazil. Brazilian Journal of Pharmaceutical Sciences, 47, 155-160.

[22]   Marcondes, N.R., Taira, C.L., Vandresen, D.C., Svidzinski, T.I.E., Kadowaki, M.K. and Peralta, R.M. (2008) New Feather-Degrading Filamentous Fungi. Microbial Ecology, 56, 13-17.

[23]   Maertens, J., Theunissen, K., Lodewyck, T., Lagrou, K. and Van Eldere, J. (2007) Advances in the Serological Diagnosis of Invasive Aspergillus Infections in Patients with Haematological Disorders. Mycoses, 50, 2-17.

[24]   Morrissey, C.O., Chen, S.C., Sorrell, T.C., Milliken, S., Bardy, P.G., Bradstock, K.F., et al. (2013) Galactomannan and PCR versus Culture and Histology for Directing Use of Antifungal Treatment for Invasive Aspergillosis in High-Risk Haematology Patients: A Randomised Controlled Trial. The Lancet Infectious Diseases, 13, 519-528.

[25]   Blair, J.E., Coakley, B., Santelli, A.C., Hentz, J.G. and Wengenack, N.L. (2006) Serologic Testing for Symptomatic Coccidioidomycosis in Immunocompetent and Immunosuppressed Hosts. Mycopathologia, 162, 317-324.